期刊文献+

慢性阻塞性肺疾病急性呼吸衰竭的治疗及预后分析 被引量:4

下载PDF
导出
摘要 研究慢性阻塞性肺疾病急性呼衰的治疗及预后。选择2014年4月~2015年1月我院收治慢性阻塞性肺疾病急性呼衰患者共50例。所有患者给予抗感染、氧疗、止咳化痰和扩张支气管等药物进行治疗,并在此基础上采用无创机械通气进行治疗。分析(1)临床疗效;(2)平均住院时间、住院费用;(3)干预前和干预后患者动脉血气分析指标、心率和呼吸频率的差异。结果:(1)经治疗,显效有27例,有效有20例,无效有3例,治疗总有效率为94.00%;(2)干预后跟干预前比较,动脉血气分析指标、心率和呼吸频率明显改善(P<0.05)。慢性阻塞性肺疾病急性呼衰在抗感染、氧疗、止咳化痰和扩张支气管等药物治疗基础上辅以无创机械通气治疗,可有效缓解患者临床症状,改善其血气分析,稳定患者生命体征,值得推广。
作者 黄运忠
出处 《现代诊断与治疗》 CAS 2017年第5期955-956,共2页 Modern Diagnosis and Treatment
  • 相关文献

二级参考文献78

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 2Briones Claudett KH, Briones Claudett M, Chung Sang Wong M, et al. Noninvasive mechanical ventilation with average volume assured pressure support(AVAPS) in patients with chronic obstructive pul- monary disease and hypereapnic encephalopathy [ J ]. BMC Pulm Med ,2013,13 (12) : 12.
  • 3Crisafulli E, Manni G, Kidonias M, et al. Subjective sleep quality during average volume assured pressure support(AYAPS) ventila- tion in patients with hypercapnic COPD:a physiological pilot study [ J]. Lung,2009,187:299-305.
  • 4HongChen,ZhenjuSong,MengjiaQian,ChunxueBai,XiangdongWang.Selection of disease‐specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study[J]. Journal of Cellular and Molecular Medicine . 2012 (6)
  • 5Karcz M, Bankey B, Schwaiberger D, et al. Acute respiratory fail- ure complicating advanced liver disease [ C ]. Semin Respir Crit Care Med,2012,33(1 ) :96-110.
  • 6Mirade P, Perret B, Guillemin H, et al. Quantifying energy sav- ings during cheese ripening after implementation of sequential air ventilation in an industrial cheesemaking plant [ J ]. Energy, 2012,46( 1 ) :248-258.
  • 7Cavari Y, Sofer S, Rozovski U, et al. Non invasive positive pres- sure ventilation in infants with respiratory failure [ J ]. Pediatric Pulmonol,2012,47 (10) : 1019-1025.
  • 8Sofia Nikolakopoulou,Georgios Hillas,Despina Perrea,Nikolaos Tentolouris,Stylianos Loukides,Konstantinos Kostikas,Davina Simoes,Erasmia Georgakopoulou,Evaggelos Vogiatzakis,Dimitrios Veldekis,Petros Bakakos.Serum Angiopoietin-2 and CRP Levels During COPD Exacerbations[J]. COPD: Journal of Chronic Obstructive Pulmonary Disease . 2014 (1)
  • 9Alain Van Meerhaeghe,Michel Vanhaeverbeek.QVA149 versus glycopyrronium for COPD[J]. The Lancet Respiratory Medicine . 2013 (5)
  • 10Mark T Dransfield,Jean Bourbeau,Paul W Jones,Nicola A Hanania,Donald A Mahler,J?rgen Vestbo,Andrew Wachtel,Fernando J Martinez,Frank Barnhart,Lisa Sanford,Sally Lettis,Courtney Crim,Peter MA Calverley.Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials[J]. The Lancet Respiratory Medicine . 2013 (3)

共引文献105

同被引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部